Literature DB >> 32135032

Effects of garlic supplementation on liver enzymes: A systematic review and meta-analysis of randomized controlled trials.

Asieh Panjeshahin1,2, Mehdi Mollahosseini1,2, Monireh Panbehkar-Jouybari1,2, Mojtaba Kaviani3, Farhang Mirzavandi1,2, Mahdieh Hosseinzadeh1,2.   

Abstract

Current evidence on the beneficial effects of garlic on liver enzymes is contradictory. Therefore, the aim of this systematic review and meta-analysis is to evaluate the effect of garlic supplementation on human liver enzymes, such as Alanine Transaminase (ALT/SGPT) and Aspartate Transaminase (AST/SGOT). To collect the required data, PubMed, Scopus, ISI Web of Science, and Google scholar databases were systematically searched from inception to June 2019. A meta-analysis was conducted using the random-effects model to evaluate the effects of garlic supplementation on ALT and AST levels. The Cochran's Q-test and inconsistency index were also used to evaluate heterogeneity among the studies. Among a total of 15,514 identified articles, six studies (containing 301 participants) met the inclusion criteria. Results of the meta-analysis showed that garlic supplementation significantly decreased AST level (Hedges' g = -0.36, 95% confidence interval [CI]: -0.72, -0.004, p = .047); whereas, it had no significant effect on ALT level (Hedges' g = -0.22, 95% CI: -0.64, 0.20, p = .310). Results showed that garlic supplementation reduced AST levels significantly; however, had no significant effect on ALT levels. Further studies are still needed to confirm the results.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ALT; AST; garlic; liver enzyme; meta-analysis; systematic review

Year:  2020        PMID: 32135032     DOI: 10.1002/ptr.6659

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  1 in total

1.  Garlic Extract Alleviates Trastuzumab-Induced Hepatotoxicity in Rats Through Its Antioxidant, Anti-Inflammatory, and Antihyperlipidemic Effects.

Authors:  Ayman M Mousa; Khaled E A Soliman; Fahad Alhumaydhi; Ahmad Almatroudi; Osamah Al Rugaie; Khaled S Allemailem; Faris Alrumaihi; Arif Khan; Mohamad Y Rezk; Mohammad Aljasir; Ameen S S Alwashmi; Faris F Aba Alkhayl; Aqel S Albutti; Hanan S Seleem
Journal:  J Inflamm Res       Date:  2021-11-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.